IRCT2016061428448N1CompletedPhase 2
Clinical trial of comparing the effect of ammonium lactate 14% and IPL versus ammonium lactate 14%-alone on keratosis pilaris
Vice Chancellor foer research of Isfahan University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •being afflicted with keratosis pilaris; patients who don't tend to only longterm and topical treatment and they prefer laser treatmen; no pregnancy and breast feeding and consent to participate in the study.
- •Exclusion criteria:sensitivity to Ammonium lactate; no regular visits and using cotreatments.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Phase 4
A study to assess the effectiveness of 2 dressings in managing the diabetic foot woundsCTRI/2024/05/068228Shahala Shirin T P
Completed
Not Applicable
effect of aromatherapy on pain, anxiety and duration of first and second stages of laborpain and anxiety and duration of first and second stages of labor.Complications of labour and deliveryO60-75IRCT2017012323370N4Vice chancellor for research, Zahedan University of Medical Sciences120
Completed
Phase 2
Investigating the effect of Albumin on urine output, using it with lasix and mannitol in ICU patients with oliguriaAcute renal failure.Acute renal failure, unspecifiedIRCT2016013010741N3Vice chancellor for research, Kerman University of Medical Sciences100
Completed
Phase 2
Effect of Capsella Bursa Pastoris on heavy menstrual bleedingMenorrhagia.excessive and frequent menstruation with regular cycleIRCT201410034529N13Vice chancellor for research Shahid Beheshti University of Medical Sciences90
Recruiting
Phase 2
Clinical trial to examine the effectiveness of AMPA-PET to identify epileptogenic focus in refractory epilepsy patientsJPRN-jRCT1080224511Tomoyuki Miyazaki (Coordinating Investigator)40
